Trial Profile
Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (Short Title (HOP-3).
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Testosterone (Primary) ; Acyline; Chorionic gonadotropin
- Indications Hypogonadism; Male infertility
- Focus Pharmacodynamics
- Acronyms HOP-3
- 30 Dec 2010 Actual initiation date (Nov 2010) added as reported by ClinicalTrials.gov.
- 30 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jun 2010 Results presented at the 92nd Annual Meeting of the Endocrine Society